Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

AGL vs MOH vs CNC vs HUM

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
AGL
Agilon Health, Inc.

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$1.01B
5Y Perf.-92.3%
MOH
Molina Healthcare, Inc.

Medical - Healthcare Plans

HealthcareNYSE • US
Market Cap$9.99B
5Y Perf.-24.8%
CNC
Centene Corporation

Medical - Healthcare Plans

HealthcareNYSE • US
Market Cap$27.13B
5Y Perf.-11.0%
HUM
Humana Inc.

Medical - Healthcare Plans

HealthcareNYSE • US
Market Cap$29.67B
5Y Perf.-44.5%

AGL vs MOH vs CNC vs HUM — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
AGL logoAGL
MOH logoMOH
CNC logoCNC
HUM logoHUM
IndustryMedical - Care FacilitiesMedical - Healthcare PlansMedical - Healthcare PlansMedical - Healthcare Plans
Market Cap$1.01B$9.99B$27.13B$29.67B
Revenue (TTM)$5.82B$45.08B$198.10B$137.20B
Net Income (TTM)$-373M$188M$-6.44B$1.13B
Gross Margin-3.9%9.6%14.9%14.0%
Operating Margin-6.8%1.2%-3.7%1.0%
Forward P/E37.2x16.3x27.7x
Total Debt$37M$3.95B$18.78B$12.94B
Cash & Equiv.$174M$4.25B$17.89B$4.20B

AGL vs MOH vs CNC vs HUMLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

AGL
MOH
CNC
HUM
StockApr 21May 26Return
Agilon Health, Inc. (AGL)1007.7-92.3%
Molina Healthcare, … (MOH)10075.2-24.8%
Centene Corporation (CNC)10089.0-11.0%
Humana Inc. (HUM)10055.5-44.5%

Price return only. Dividends and distributions are not included.

Quick Verdict: AGL vs MOH vs CNC vs HUM

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: HUM leads in 4 of 7 categories, making it the strongest pick for profitability and margin quality and dividend income and shareholder returns. Centene Corporation is the stronger pick specifically for growth and revenue expansion and valuation and capital efficiency. As sector peers, any of these can serve as alternatives in the same allocation.
AGL
Agilon Health, Inc.
The Specific-Use Pick

AGL plays a supporting role in this comparison — it may shine differently against other peers.

Best for: healthcare exposure
MOH
Molina Healthcare, Inc.
The Insurance Pick

MOH is the clearest fit if your priority is growth exposure and long-term compounding.

  • Rev growth 11.7%, EPS growth -56.3%, 3Y rev CAGR 12.4%
  • 306.6% 10Y total return vs CNC's 81.2%
Best for: growth exposure and long-term compounding
CNC
Centene Corporation
The Insurance Pick

CNC is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.

  • Dividend streak 1 yrs, beta 0.39
  • Lower volatility, beta 0.39, Low D/E 93.6%, current ratio 1.68x
  • Beta 0.39, current ratio 1.68x
  • 19.4% revenue growth vs AGL's -2.1%
Best for: income & stability and sleep-well-at-night
HUM
Humana Inc.
The Insurance Pick

HUM carries the broadest edge in this set and is the clearest fit for quality and dividends.

  • 0.8% margin vs AGL's -6.4%
  • 1.4% yield; the other 3 pay no meaningful dividend
  • -1.0% vs MOH's -41.3%
  • 2.2% ROA vs AGL's -24.5%, ROIC 4.1% vs -203.2%
Best for: quality and dividends
See the full category breakdown
CategoryWinnerWhy
GrowthCNC logoCNC19.4% revenue growth vs AGL's -2.1%
ValueCNC logoCNCLower P/E (16.3x vs 27.7x)
Quality / MarginsHUM logoHUM0.8% margin vs AGL's -6.4%
Stability / SafetyCNC logoCNCBeta 0.39 vs AGL's 2.98
DividendsHUM logoHUM1.4% yield; the other 3 pay no meaningful dividend
Momentum (1Y)HUM logoHUM-1.0% vs MOH's -41.3%
Efficiency (ROA)HUM logoHUM2.2% ROA vs AGL's -24.5%, ROIC 4.1% vs -203.2%

AGL vs MOH vs CNC vs HUM — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

AGLAgilon Health, Inc.
FY 2025
Medical Services
99.8%$5.9B
Other Operating
0.2%$11M
MOHMolina Healthcare, Inc.
FY 2025
Medicaid Solutions Segment
74.7%$32.2B
Medicare
14.5%$6.2B
Marketplace
10.4%$4.5B
Other Segments
0.4%$177M
CNCCentene Corporation
FY 2025
Medicaid Segment
75.8%$147.6B
Commercial Segment
21.6%$42.0B
Other Operating Segment
2.6%$5.1B
HUMHumana Inc.
FY 2025
Insurance Segment
84.7%$124.6B
CenterWell Segment
15.3%$22.5B

AGL vs MOH vs CNC vs HUM — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLCNCLAGGINGHUM

Income & Cash Flow (Last 12 Months)

Evenly matched — CNC and HUM each lead in 2 of 6 comparable metrics.

CNC is the larger business by revenue, generating $198.1B annually — 34.0x AGL's $5.8B. HUM is the more profitable business, keeping 0.8% of every revenue dollar as net income compared to AGL's -6.4%. On growth, HUM holds the edge at +23.5% YoY revenue growth, suggesting stronger near-term business momentum.

MetricAGL logoAGLAgilon Health, In…MOH logoMOHMolina Healthcare…CNC logoCNCCentene Corporati…HUM logoHUMHumana Inc.
RevenueTrailing 12 months$5.8B$45.1B$198.1B$137.2B
EBITDAEarnings before interest/tax-$366M$710M-$5.9B$2.2B
Net IncomeAfter-tax profit-$373M$188M-$6.4B$1.1B
Free Cash FlowCash after capex-$77M$251M$6.3B$1.3B
Gross MarginGross profit ÷ Revenue-3.9%+9.6%+14.9%+14.0%
Operating MarginEBIT ÷ Revenue-6.8%+1.2%-3.7%+1.0%
Net MarginNet income ÷ Revenue-6.4%+0.4%-3.3%+0.8%
FCF MarginFCF ÷ Revenue-1.3%+0.6%+3.2%+0.9%
Rev. Growth (YoY)Latest quarter vs prior year-7.3%-3.1%+7.1%+23.5%
EPS Growth (YoY)Latest quarter vs prior year+140.0%-95.0%+18.3%-4.6%
Evenly matched — CNC and HUM each lead in 2 of 6 comparable metrics.

Valuation Metrics

CNC leads this category, winning 5 of 6 comparable metrics.

At 21.5x trailing earnings, MOH trades at a 14% valuation discount to HUM's 25.1x P/E. On an enterprise value basis, MOH's 9.9x EV/EBITDA is more attractive than HUM's 16.9x.

MetricAGL logoAGLAgilon Health, In…MOH logoMOHMolina Healthcare…CNC logoCNCCentene Corporati…HUM logoHUMHumana Inc.
Market CapShares × price$1.0B$10.0B$27.1B$29.7B
Enterprise ValueMkt cap + debt − cash$873M$9.7B$28.0B$38.4B
Trailing P/EPrice ÷ TTM EPS-2.48x21.50x-4.03x25.12x
Forward P/EPrice ÷ next-FY EPS est.37.20x16.29x27.68x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple9.93x16.87x
Price / SalesMarket cap ÷ Revenue0.17x0.22x0.14x0.23x
Price / BookPrice ÷ Book value/share7.92x2.39x1.35x1.68x
Price / FCFMarket cap ÷ FCF6.28x79.13x
CNC leads this category, winning 5 of 6 comparable metrics.

Profitability & Efficiency

Evenly matched — MOH and HUM each lead in 3 of 9 comparable metrics.

HUM delivers a 6.2% return on equity — every $100 of shareholder capital generates $6 in annual profit, vs $-146 for AGL. AGL carries lower financial leverage with a 0.29x debt-to-equity ratio, signaling a more conservative balance sheet compared to MOH's 0.97x. On the Piotroski fundamental quality scale (0–9), CNC scores 6/9 vs AGL's 2/9, reflecting solid financial health.

MetricAGL logoAGLAgilon Health, In…MOH logoMOHMolina Healthcare…CNC logoCNCCentene Corporati…HUM logoHUMHumana Inc.
ROE (TTM)Return on equity-146.0%+4.4%-28.6%+6.2%
ROA (TTM)Return on assets-24.5%+1.2%-7.9%+2.2%
ROICReturn on invested capital-2.0%+17.4%-21.6%+4.1%
ROCEReturn on capital employed-108.4%+9.8%-14.6%+4.0%
Piotroski ScoreFundamental quality 0–92465
Debt / EquityFinancial leverage0.29x0.97x0.94x0.73x
Net DebtTotal debt minus cash-$137M-$298M$889M$8.7B
Cash & Equiv.Liquid assets$174M$4.2B$17.9B$4.2B
Total DebtShort + long-term debt$37M$4.0B$18.8B$12.9B
Interest CoverageEBIT ÷ Interest expense-119.84x2.12x-9.03x3.08x
Evenly matched — MOH and HUM each lead in 3 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

CNC leads this category, winning 3 of 6 comparable metrics.

A $10,000 investment in CNC five years ago would be worth $7,800 today (with dividends reinvested), compared to $724 for AGL. Over the past 12 months, HUM leads with a -1.0% total return vs MOH's -41.3%. The 3-year compound annual growth rate (CAGR) favors CNC at -7.0% vs AGL's -54.6% — a key indicator of consistent wealth creation.

MetricAGL logoAGLAgilon Health, In…MOH logoMOHMolina Healthcare…CNC logoCNCCentene Corporati…HUM logoHUMHumana Inc.
YTD ReturnYear-to-date+260.1%+7.5%+31.5%-6.2%
1-Year ReturnPast 12 months-28.4%-41.3%-12.7%-1.0%
3-Year ReturnCumulative with dividends-90.6%-35.0%-19.5%-51.9%
5-Year ReturnCumulative with dividends-92.8%-28.4%-22.0%-43.3%
10-Year ReturnCumulative with dividends-92.2%+306.6%+81.2%+59.8%
CAGR (3Y)Annualised 3-year return-54.6%-13.4%-7.0%-21.7%
CNC leads this category, winning 3 of 6 comparable metrics.

Risk & Volatility

Evenly matched — MOH and CNC each lead in 1 of 2 comparable metrics.

MOH is the less volatile stock with a -0.04 beta — it tends to amplify market swings less than AGL's 2.98 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CNC currently trades 85.7% from its 52-week high vs AGL's 50.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricAGL logoAGLAgilon Health, In…MOH logoMOHMolina Healthcare…CNC logoCNCCentene Corporati…HUM logoHUMHumana Inc.
Beta (5Y)Sensitivity to S&P 5002.98x-0.04x0.39x0.56x
52-Week HighHighest price in past year$119.50$333.00$64.15$315.35
52-Week LowLowest price in past year$0.97$121.06$25.08$163.11
% of 52W HighCurrent price vs 52-week peak+50.8%+57.6%+85.7%+78.4%
RSI (14)Momentum oscillator 0–10060.477.183.576.6
Avg Volume (50D)Average daily shares traded373K1.4M5.8M1.6M
Evenly matched — MOH and CNC each lead in 1 of 2 comparable metrics.

Analyst Outlook

CNC leads this category, winning 1 of 1 comparable metric.

Analyst consensus: AGL as "Hold", MOH as "Buy", CNC as "Buy", HUM as "Hold". Consensus price targets imply -0.5% upside for HUM (target: $246) vs -59.6% for AGL (target: $25). HUM is the only dividend payer here at 1.44% yield — a key consideration for income-focused portfolios.

MetricAGL logoAGLAgilon Health, In…MOH logoMOHMolina Healthcare…CNC logoCNCCentene Corporati…HUM logoHUMHumana Inc.
Analyst RatingConsensus buy/hold/sellHoldBuyBuyHold
Price TargetConsensus 12-month target$24.50$166.09$51.00$246.00
# AnalystsCovering analysts25384344
Dividend YieldAnnual dividend ÷ price+1.4%
Dividend StreakConsecutive years of raises10
Dividend / ShareAnnual DPS$3.56
Buyback YieldShare repurchases ÷ mkt cap+0.3%+10.0%+1.8%+0.5%
CNC leads this category, winning 1 of 1 comparable metric.
Key Takeaway

CNC leads in 3 of 6 categories — strongest in Valuation Metrics and Total Returns. 3 categories are tied.

Best OverallCentene Corporation (CNC)Leads 3 of 6 categories
Loading custom metrics...

AGL vs MOH vs CNC vs HUM: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is AGL or MOH or CNC or HUM a better buy right now?

For growth investors, Centene Corporation (CNC) is the stronger pick with 19.

4% revenue growth year-over-year, versus -2. 1% for Agilon Health, Inc. (AGL). Molina Healthcare, Inc. (MOH) offers the better valuation at 21. 5x trailing P/E (37. 2x forward), making it the more compelling value choice. Analysts rate Molina Healthcare, Inc. (MOH) a "Buy" — based on 38 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — AGL or MOH or CNC or HUM?

On trailing P/E, Molina Healthcare, Inc.

(MOH) is the cheapest at 21. 5x versus Humana Inc. at 25. 1x. On forward P/E, Centene Corporation is actually cheaper at 16. 3x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — AGL or MOH or CNC or HUM?

Over the past 5 years, Centene Corporation (CNC) delivered a total return of -22.

0%, compared to -92. 8% for Agilon Health, Inc. (AGL). Over 10 years, the gap is even starker: MOH returned +306. 6% versus AGL's -92. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — AGL or MOH or CNC or HUM?

By beta (market sensitivity over 5 years), Molina Healthcare, Inc.

(MOH) is the lower-risk stock at -0. 04β versus Agilon Health, Inc. 's 2. 98β — meaning AGL is approximately -8243% more volatile than MOH relative to the S&P 500. On balance sheet safety, Agilon Health, Inc. (AGL) carries a lower debt/equity ratio of 29% versus 97% for Molina Healthcare, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — AGL or MOH or CNC or HUM?

By revenue growth (latest reported year), Centene Corporation (CNC) is pulling ahead at 19.

4% versus -2. 1% for Agilon Health, Inc. (AGL). On earnings-per-share growth, the picture is similar: Humana Inc. grew EPS -1. 4% year-over-year, compared to -315. 8% for Centene Corporation. Over a 3-year CAGR, AGL leads at 35. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — AGL or MOH or CNC or HUM?

Molina Healthcare, Inc.

(MOH) is the more profitable company, earning 1. 0% net margin versus -6. 8% for Agilon Health, Inc. — meaning it keeps 1. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MOH leads at 1. 7% versus -7. 1% for AGL. At the gross margin level — before operating expenses — HUM leads at 14. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is AGL or MOH or CNC or HUM more undervalued right now?

On forward earnings alone, Centene Corporation (CNC) trades at 16.

3x forward P/E versus 37. 2x for Molina Healthcare, Inc. — 20. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for HUM: -0. 5% to $246. 00.

08

Which pays a better dividend — AGL or MOH or CNC or HUM?

In this comparison, HUM (1.

4% yield) pays a dividend. AGL, MOH, CNC do not pay a meaningful dividend and should not be held primarily for income.

09

Is AGL or MOH or CNC or HUM better for a retirement portfolio?

For long-horizon retirement investors, Molina Healthcare, Inc.

(MOH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 04), +306. 6% 10Y return). Agilon Health, Inc. (AGL) carries a higher beta of 2. 98 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MOH: +306. 6%, AGL: -92. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between AGL and MOH and CNC and HUM?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: AGL is a small-cap quality compounder stock; MOH is a small-cap quality compounder stock; CNC is a mid-cap high-growth stock; HUM is a mid-cap quality compounder stock. HUM pays a dividend while AGL, MOH, CNC do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

AGL

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

MOH

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

CNC

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
Run This Screen
Stocks Like

HUM

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 11%
  • Dividend Yield > 0.5%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform AGL and MOH and CNC and HUM on the metrics below

Revenue Growth>
%
(AGL: -7.3% · MOH: -3.1%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.